FDA approves Lilly’s Inluriyo-Verzenio combo for breast cancer
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Coffee Break: Reading for Health, AI Language, AI in Medicine, and Environmental Action
Part the First: And in Other News, What Really Maintains Brain Health. Big brother obviously knows how old I am. That’s the only explanation for why he litters my screen with ads for old people things…
How a single viral protein hijacks immune cells to supercharge COVID-19 infection
In the sickest COVID-19 patients, SARS-CoV-2 doesn't just cause severe damage by directly infecting airway cells. The virus can also trigger hyperinflammation—a cycle in which immune cells themselves…
Gene that drives blood cancer drug resistance uncovered with new CRISPR activation tool
Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR…
Do antidepressants actually alter brain structure? A massive neuroscience study weighs in
A sweeping new study of nearly 8,700 brain scans found that subtle structural differences in people taking antidepressants are mostly explained by the severity of their illness and their age, rather…
Watch live: Trump to announce Medicaid drug pricing plan
President Trump will deliver remarks Friday on another step in his administration’s efforts to lower prescription drug costs.